Search

Your search keyword '"Carere RG"' showing total 96 results

Search Constraints

Start Over You searched for: Author "Carere RG" Remove constraint Author: "Carere RG"
96 results on '"Carere RG"'

Search Results

1. Incidence, predictors, and significance of abnormal cardiac enzyme rise in patients treated with bypass surgery in the arterial revascularization therapies study (ARTS)

2. Multicenter evaluation of the phosphorylcholinecoated biodivYsio stent in short de novo coronary lesions: The SOPHOS study

4. Association of the arterial access site at angioplasty with transfusion and mortality: the M.O.R.T.A.L study (Mortality benefit Of Reduced Transfusion after percutaneous coronary intervention via the Arm or Leg)

9. Multicenter evaluation of the phosphorylcholinecoated biodivYsio stent in short de novo coronary lesions: The SOPHOS study

10. Abbreviated infusion of eptifibatide after successful coronary intervention The BRIEF-PCI (Brief Infusion of Eptifibatide Following Percutaneous Coronary Intervention) randomized trial.

11. Outcomes of transcatheter pulmonary SAPIEN 3 valve implantation: an international registry.

12. Early outcomes of percutaneous pulmonary valve implantation using the Edwards SAPIEN 3 transcatheter heart valve system.

13. Early leaflet thrombosis complicating transcatheter implantation of a Sapien 3 valve in a native right ventricular outflow tract.

14. Early outcomes of percutaneous pulmonary valve implantation using the Edwards SAPIEN XT transcatheter heart valve system.

15. Quality of Care for Percutaneous Coronary Intervention: Development of Canadian Cardiovascular Society Quality Indicators.

16. A Plaque Disruption Index Identifies Patients with Non-STE-Type 1 Myocardial Infarction within 24 Hours of Troponin Positivity.

17. Prolonged Clopidogrel Use is Associated with Improved Clinical Outcomes Following Drug-Eluting But Not Bare Metal Stent Implantation.

18. Delay in filling first clopidogrel prescription after coronary stenting is associated with an increased risk of death and myocardial infarction.

19. Customized covered stent graft for percutaneous closure of Fontan baffle leak.

20. Non-red blood cell transfusion as a risk factor for mortality following percutaneous coronary intervention.

21. Pathology of transcatheter valve therapy.

22. First-in-man use of a tapered endovascular stent graft for treatment of aneurysm after coarctation repair.

23. Transatrial transcatheter tricuspid valve-in-valve implantation of balloon expandable bioprosthesis.

24. A proposed clinical model for efficient utilization of invasive coronary angiography.

25. Technical considerations to avoid pitfalls during transapical aortic valve implantation.

26. Red blood cell storage duration and mortality in patients undergoing percutaneous coronary intervention.

27. Transapical transcatheter aortic valve implantation: follow-up to 3 years.

28. Transcatheter valve-in-valve implantation for failed bioprosthetic heart valves.

29. Current balloon-expandable transcatheter heart valve and delivery systems.

30. Transcatheter valve-in-valve aortic valve implantation: 16-month follow-up.

31. Percutaneous coronary intervention in the Occluded Artery Trial: procedural success, hazard, and outcomes over 5 years.

32. CT of the ilio-femoral arteries using direct aortic contrast injection: proof of feasibility in patients screened towards percutaneous aortic valve replacement.

33. Effect of operator and institutional volume on clinical outcomes after percutaneous coronary interventions performed in Canada and the United States: a brief report from the Enhanced Suppression of the Platelet glycoprotein IIb/IIIa Receptor with Integrilin Therapy (ESPRIT) study.

34. Mitral valve injury late after transcatheter aortic valve implantation.

35. Angiographic and clinical outcomes of drug-eluting versus bare metal stent deployment in the Occluded Artery Trial.

36. Transapical transcatheter mitral valve-in-valve implantation in a human.

37. Transapical transcatheter aortic valve implantation: 1-year outcome in 26 patients.

38. Prevention and management of transcatheter balloon-expandable aortic valve malposition.

39. Angina with "normal" coronary arteries: sex differences in outcomes.

40. Six-month outcome of transapical transcatheter aortic valve implantation in the initial seven patients.

41. Changing outcomes of coronary revascularization in British Columbia, 1995-2001.

42. Percutaneous aortic valve implantation: a case report.

43. Transapical aortic valve implantation in humans.

44. Effect of percutaneous coronary intervention of nonacute total coronary artery occlusions on QT dispersion.

45. Percutaneous occlusion of a pulmonary aneurysm causing hemoptysis in a patient with pulmonary atresia and aortopulmonary collaterals.

46. Cross-provincial use of cardiac services: the importance of data-sharing for clinical registries and outcomes research.

47. Revascularization use and survival outcomes after cardiac catheterization in British Columbia and Alberta.

48. A comparison of clinical outcomes between Canadian and American patients after nonurgent coronary stenting.

49. Procedural efficacy and complications of X-Sizer thrombectomy in de novo and stented lesions.

50. Population rates of invasive cardiac procedures in British Columbia, 1995 to 2001.

Catalog

Books, media, physical & digital resources